Product News

Lipercosyl® is the first statin and ACEi combination available in Ireland.

Lipercosyl

Servier Laboratories (Ireland) Ltd are delighted to announce that Lipercosyl®, the combination of atorvastatin and perindopril, will be available for prescription from February 2021 and is listed as a PCRS reimbursable product.

Lipercosyl® is the first statin and ACEi combination available in Ireland12. It controls both high cholesterol and hypertension in tandem1. This combination will help patients achieve their lower LDL-C and blood pressure targets4,5.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free